Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-10-26, Stock:JNJ, The news for the past five days is as follows:
2020-10-19: NEWS1: Analyst's Potential Buyout List Includes Alexion, Amarin and Biomarin.NEWS2: Stock Market Today: Investors Lose Their Nerve as Relief Deadline Nears.NEWS3: ‘The most difficult phase of the epidemic is ahead of us’: doctor.NEWS4: Johnson & Johnson stock falls Monday, underperforms market.NEWS5: 'Not just him': What Trump's antibody use says about the future of coronavirus treatments.NEWS6: 2 Stocks to Supplement Your Social Security Income.NEWS7: Coronavirus cases surpass 40 million across the globe, 8 million in the U.S..
2020-10-20: NEWS1: Johnson & Johnson stock rises Tuesday, still underperforms market.NEWS2: Coronavirus Latest: Tuesday, October 20.NEWS3: Covid-19 Vaccines Could Take a Critical Next Step in November — Just Not In Time for the Election.NEWS4: Were Hedge Funds Right About Piling Into Johnson & Johnson (JNJ)?.NEWS5: Moderna's COVID-19 vaccine timeline.NEWS6: Now Is the Time to Go All-In on These 3 Breakout Stocks.
2020-10-21: NEWS1: Coronavirus Latest: Wednesday, October 21.NEWS2: Johnson & Johnson stock falls Wednesday, underperforms market.NEWS3: Sorrento Therapeutics Is a Vaccine Movie That Investors Have Already Seen.NEWS4: 2 Late-Stage Coronavirus Vaccine Candidates in Limbo.NEWS5: Dow Stutters as Traders Continue to Sweat on Stimulus Progress.NEWS6: OxyContin maker Purdue reaches plea deal in opioid probe-sources.NEWS7: EU signs supply deal with J&J on potential COVID-19 vaccine.
2020-10-22: NEWS1: US faces major hurdles for COVID-19 vaccine distribution: Vaccine advisory committee.NEWS2: Moderna Covid-19 Vaccine Nears; Passes Key Milestone In Final Testing.NEWS3: Johnson & Johnson stock outperforms market on strong trading day.NEWS4: Coronavirus Latest: Thursday, October 22.NEWS5: Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2020.NEWS6: FDA Covid Meeting Shows the Companies Behind the Vaccines.NEWS7: Pfizer, Moderna Vaccines, Gilead Treatment In Focus As Health Firms Report Q3 Earnings.NEWS8: JNJ Stock: Break Of Support Presents Bearish Option Trade.NEWS9: Pfizer, J&J urge clarity from FDA on future of COVID-19 vaccine trials once a vaccine is available.NEWS10: Glaxo Vaccines Target Another Viral Threat.NEWS11: AstraZeneca (AZN), J&J (JNJ) Coronavirus Trials May Resume Soon.NEWS12: What to expect from the FDA's COVID-19 vaccine meeting today.NEWS13: Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus.NEWS14: Intuitive Surgical Says Outlook Still Murky — Is ISRG Stock A Buy?.NEWS15: Intuitive Surgical Says Outlook Still Murky — Is ISRG Stock A Buy?.
2020-10-23: NEWS1: Is Kimberly-Clark's Pullback an Opportunity to Buy?.NEWS2: J&J to resume U.S. part of COVID-19 vaccine clinical trial.NEWS3: Johnson & Johnson Covid-19 Vaccine Trial Set to Resume.NEWS4: Remdesivir ‘is not a knock out punch’ but it does help patients ‘recover quicker’: doctor.NEWS5: Johnson & Johnson stock rises Friday, still underperforms market.NEWS6: J&J preparing to resume U.S. trial of COVID-19 vaccine candidate.NEWS7: WRAPUP 8-AstraZeneca resumes U.S. COVID-19 vaccine trial and next week J&J prepares to do same.NEWS8: Pharmaceutical companies ‘are doing a good job’ with efficacy and transparency: physician.NEWS9: Johnson & Johnson coronavirus vaccine trial to resume soon - Washington Post.NEWS10: Can Novavax Stock Overcome Growing Vaccine Distrust?.NEWS11: Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus.NEWS12: COVID-19 'Pool testing' in schools would give insight on how well masks in schools are doing: Dr. Dara Kass.

Answer: Decrease